Thrombolysis in acute experimental myocardial infarction

Area of Science:

• Cardiovascular Research
• Thrombolytic Therapy
• Experimental Cardiology

Background:

• Intracoronary streptokinase is a therapeutic option for acute myocardial infarction.
• A reliable experimental model is needed to study thrombolysis in myocardial infarction.

Purpose of the Study:

• To develop and validate a canine model simulating thrombotic coronary occlusion in acute myocardial infarction.
• To evaluate the efficacy of intracoronary streptokinase in restoring blood flow and preserving myocardial tissue in this model.

Main Methods:

• A stenotic coronary artery model was created in 20 dogs using ligations and thrombin injection.
• Streptokinase was infused into the left main coronary artery at varying occlusion times (1-6 hours).
• Hemodynamic variables, coronary blood flow, and myocardial perfusion were continuously monitored; infarct size was assessed postmortem.

Main Results:

• Streptokinase successfully reinstated blood flow and normalized myocardial perfusion in ischemic areas, with faster reperfusion correlating with shorter occlusion times.
• Over 50% of viable myocardium was preserved even after 6 hours of occlusion.
• Hemorrhage was limited, and serious reperfusion arrhythmias were primarily observed after shorter occlusion periods.

Conclusions:

• The developed canine model effectively simulates acute myocardial infarction and allows for the evaluation of thrombolytic therapy.
• Intracoronary streptokinase demonstrates significant efficacy in salvaging myocardium and restoring perfusion in this experimental model.
• The findings support the clinical use of streptokinase for acute myocardial infarction, with potential benefits in reducing infarct size and managing reperfusion complications.